NasdaqCM - Delayed Quote • USD
TRACON Pharmaceuticals, Inc. (TCON)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
12,045.0000
12,045.0000
--
346.0000
--
Operating Expense
18,943.0000
18,943.0000
27,894.0000
28,693.0000
16,223.0000
Operating Income
-6,898.0000
-6,898.0000
-27,894.0000
-28,347.0000
-16,223.0000
Net Non Operating Interest Income Expense
-7,304.0000
-7,304.0000
-994.0000
-318.0000
-545.0000
Other Income Expense
10,614.0000
10,614.0000
-247.0000
-2.0000
-7.0000
Pretax Income
-3,588.0000
-3,588.0000
-29,135.0000
-28,667.0000
-16,775.0000
Net Income Common Stockholders
-3,588.0000
-3,588.0000
-29,135.0000
-28,667.0000
-16,775.0000
Diluted NI Available to Com Stockholders
-3,588.0000
-3,588.0000
-29,135.0000
-28,667.0000
-16,775.0000
Basic EPS
-0.11
--
-1.39
-1.66
-1.87
Diluted EPS
-0.11
--
-1.39
-1.66
-1.87
Basic Average Shares
32,745.7080
--
20,919.1180
17,252.6370
8,984.1480
Diluted Average Shares
32,745.7080
--
20,919.1180
17,252.6370
8,984.1480
Total Operating Income as Reported
-9,273.0000
-9,273.0000
-27,894.0000
-28,347.0000
-16,223.0000
Total Expenses
18,943.0000
18,943.0000
27,894.0000
28,693.0000
16,223.0000
Net Income from Continuing & Discontinued Operation
-3,588.0000
-3,588.0000
-29,135.0000
-28,667.0000
-16,775.0000
Normalized Income
-1,213.0000
-1,213.0000
-29,135.0000
-28,667.0000
-16,775.0000
Interest Expense
7,304.0000
7,304.0000
994.0000
318.0000
545.0000
Net Interest Income
-7,304.0000
-7,304.0000
-994.0000
-318.0000
-545.0000
EBIT
3,716.0000
3,716.0000
-28,141.0000
-28,349.0000
-16,230.0000
EBITDA
3,750.0000
3,750.0000
-28,071.0000
-28,349.0000
-16,230.0000
Reconciled Depreciation
34.0000
34.0000
70.0000
-59.0000
-13.0000
Net Income from Continuing Operation Net Minority Interest
-3,588.0000
-3,588.0000
-29,135.0000
-28,667.0000
-16,775.0000
Total Unusual Items Excluding Goodwill
-2,375.0000
-2,375.0000
--
--
--
Total Unusual Items
-2,375.0000
-2,375.0000
--
--
--
Normalized EBITDA
6,125.0000
6,125.0000
-28,071.0000
-28,349.0000
-16,230.0000
12/31/2020 - 1/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRXP NRx Pharmaceuticals, Inc.
3.5400
+12.74%
EYEN Eyenovia, Inc.
0.6282
-11.68%
ASLN ASLAN Pharmaceuticals Limited
0.4153
-7.30%
GLMD Galmed Pharmaceuticals Ltd.
0.3916
+0.90%
CDTX Cidara Therapeutics, Inc.
12.63
-2.85%
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
CNTB Connect Biopharma Holdings Limited
1.3400
-0.74%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.9900
+0.34%
RNAZ TransCode Therapeutics, Inc.
0.5499
+5.30%
JAGX Jaguar Health, Inc.
0.1800
+5.88%